Dantrolene Sodium
13 NDCs across 6 manufacturers|13 Generic,0 Brand
Dantrolene Sodium is used to treat cerebral infarction, cerebral palsy, malignant hyperthermia, multiple sclerosis, muscle spasticity and neuroleptic malignant syndrome, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Mar 1, 2005. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $4 million on Dantrolene Sodium across 43,000 claims for 6,679 beneficiaries.
Dantrolene Sodium is available as 13 NDCs from 6 manufacturers (13 generic, 0 brand), with NADAC prices from $0.41 to $1.01 per EA — the most expensive product costs about 2.5× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
13
13G / 0B
Manufacturers
6
competing in market
Price Spread
$0.41 – $1.01
per EA
7d Activity
avg -3.0% WoW · of 13 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amneal Pharmaceuticals of New York LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Skeletal Muscle Relaxant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing DANTROLENE SODIUM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DANTROLENE SODIUM 100 MG CAP | $1.0073 per EA | +1.63% |
DANTROLENE SODIUM 100 MG CAP | $1.0073 per EA | +1.63% |
DANTROLENE SODIUM 100 MG CAP | $1.0073 per EA | +1.63% |
DANTROLENE SODIUM 25 MG CAP | $0.7194 per EA | — |
DANTROLENE SODIUM 50 MG CAP | $0.5538 per EA | -3.50% |
DANTROLENE SODIUM 50 MG CAP | $0.5538 per EA | -3.50% |
DANTROLENE SODIUM 50 MG CAP | $0.5538 per EA | -3.50% |
DANTROLENE SODIUM 25 MG CAP | $0.4088 per EA | -5.03% |
DANTROLENE SODIUM 25 MG CAP | $0.4088 per EA | -5.03% |
DANTROLENE SODIUM 25 MG CAP | $0.4088 per EA | -5.03% |
DANTROLENE SODIUM 25 MG CAP | $0.4088 per EA | -5.03% |
DANTROLENE SODIUM 25 MG CAP | $0.4088 per EA | -5.03% |
DANTROLENE SODIUM 25 MG CAP | $0.4088 per EA | -5.03% |
Frequently Asked Questions
What is Dantrolene Sodium used to treat?
Dantrolene Sodium is used to treat cerebral infarction, cerebral palsy, malignant hyperthermia, multiple sclerosis, muscle spasticity and neuroleptic malignant syndrome, per the National Library of Medicine's MED-RT classification.
When did Dantrolene Sodium become available as a generic?
FDA approved the first generic Dantrolene Sodium (ANDA) on Mar 1, 2005. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dantrolene Sodium?
In 2024, Medicare Part D spent $4 million on Dantrolene Sodium across 43,000 claims for 6,679 beneficiaries.
How many Dantrolene Sodium products are on the market?
The Dantrolene Sodium drug market contains 13 NDCs from 6 manufacturers — 13 generic and 0 brand products.
What is the price range for Dantrolene Sodium?
NADAC reference prices for Dantrolene Sodium range from $0.4088 to $1.0073 per EA — the most expensive product costs about 2.5× the cheapest.
Which manufacturers make Dantrolene Sodium?
6 manufacturers list Dantrolene Sodium in NADAC. Ranked by number of NDCs, the largest are Amneal Pharmaceuticals of New York LLC (4), Endo USA Inc. (3), Elite Laboratories, Inc. (3), American Health Packaging (1), Major Pharmaceuticals (1).
How has the price of Dantrolene Sodium changed recently?
Over the past 7 days, 3 Dantrolene Sodium NDCs rose and 9 fell, with a market-wide average change of -3.0%.